medigraphic.com

2017, Number 5

Next >>

Rev Clin Esc Med 2017; 7 (5)

Patogénesis del VIH/SIDA

Boza CR

Language: Spanish
References: 39
Page: 28-46
PDF size: 350.90 Kb.


ABSTRACT

In 1981 a new syndrome appeared in human populations in the United States characterized by a deficiency in the immune system. Patients presented with unusual infections and cancer and a new acquired immune deficiency was postulated. A great progress has been made in the last years about its epidemiology, pathogenesis and treatment. Comprehension about the pathogenic course of this disorder is basic for the clinical and treatment understanding of HIV/AIDS. In this review we analyzed the normal immune response, general characteristics of HIV, its life cycle, its evolution and natural history and chronic inflammation associated disorders.


REFERENCES

  1. Boza R. Orígenes del VIH/sida. Rev Clin Esc Med UCR-HSJD 2016;6:48- 60

  2. UNAIDS Global AIDS UPDATE 2016

  3. Delves PJ Martin SJ Burton DR Roitt IM. Roitt’s Essential Immunology. Wiley Blackwell Oxford 13th Edition 2017.

  4. Gottlieb MS Schroff R Schanker HM et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men. Evidence of a new acquired cellular immunodeficiency. N Engl J Med 1981;305:1425- 1431.

  5. Masur H Michelle MA Greene JB et al. An outbreak of community-acquired Pneumocystis carinii pneumonia. Initial manifestation of cellular immune dysfunction. N Engl J Med 1981;305:1431- 1438.

  6. Begoña Vázquez M Sureda M Rebollo J. Células dendríticas l: aspectos básicos de su biología y funciones. Inmunología 2012;31:21-30.

  7. Hoffman J van Griesven J Colebunders R et al. Role of the CD4 Count in HIV Management. HIV Therapy 2010; 4:2739.

  8. Reitz MS Gallo RC. Human Immunodeficiency Virus in Bennett JE Dolin R Blaser MJ Mandell’s Principles and Practice of Infectious Diseases. Elsevier Philadelphia 8th Edition 2015; 2054- 2062

  9. Swanstrom R Coffin J HIV-1. Pathogenesis: The Virus Cold Spring. Harb Perspect Med 2012;2:a007443

  10. Ndgun’u T Weiss RA. On HIV diversity. AIDS 2012, 2 6:1255–1260.

  11. Levy JA. HIV pathogenesis: 25 years of progress and persistent challenges. AIDS 2009;23:147-160.

  12. Murphy EL Bruhn R. Human T-Lymphotropic Virus in Bennett JE Dolin R Blaser MJ Mandell’s Principles and Practice of Infectious Diseases. Elsevier Philadelphia 8th Edition 2015; 2054- 2062

  13. Gonzalez-Alcaide G Ramos JM Huamani C et al. Human T-Lymphotropic Virus 1 (HTLV-1) and Human T-Lymphotropic Virus 2 (HTLV-2): Geographical Research Trends and Collaboration Networks (1989-2012). Rev. Inst. Med. Trop. Sao Paulo 2016;58: 11-21.

  14. Ho YC Shan L Hosmane NN et al. Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure. Cell 2013;155:540–550.

  15. Maartens G Celum C Lewin Sh. HIV infection: epidemiology, pathogenesis, treatment and prevention. Lancet 2014;384:258-271

  16. Bharwaj N Hladik F Moir S. The Immune response to HIV Nature. Reviews Immunology 2012/poster.

  17. Harper KN. HIV altered microbioma may be driving disease progression. AIDS 2017;31:N1.

  18. Somsouk M Estes JD Deleage C. et al. Gut epithelial barrier and systemic inflammation during chronic HIV infection. AIDS 2015;29:43-51.

  19. Wang H Kotler DP. HIV enteropathy and aging: gastrointestinal immunity, mucosal epithelial barrier, and microbial translocation. Curr Opin HIV AIDS 2014;9:309-316.

  20. Dadenkar S George M Baumler AJ. Th17 cells, HIV and the gut mucosal barrier. Curr Opin HIV AIDS 2010;5:173-178.

  21. Deeks SG. HIV Infection, Inflamation, Immunosenescense, and Aging. Ann Rev Med 2011;62:141-155.

  22. Hunt PW Sinclair E Rodríguez B et al. Gut Epithelial Barrier Dysfunction and Innate Immune Activation Predict Mortality in Treated HIV. Infection J Infect Dis 2014;210:1228-1238.

  23. Boulougoura A Sereti I. HIV Infection and Immune activation: the role of coinfections. Curr Opin HIV AIDS 2016;11:191–200.

  24. Appay V Kelleher AD. Immune activation and immune aging in HIV infection. Curr Opin HIV AIDS 2016: 11:242– 249.

  25. Cao W Mehraj V Kaufmann DE et al. Elevation and persistence of CD8+T cells in HIV infection: the Achilles heel in the ART era. e-JIAS 2016;19:20697.

  26. Helleberg M Kronborg G Ullum H et al. Course and Clinical Significance of CD8+ T-Cell Counts in a Large Cohort of HIV-Infected Individuals. J Infect Dis 2015;211:1726–1734.

  27. Serrano-Villar S Deeks S. CD4/CD8 ratio: an emerging biomarker for HIV. Lancet HIV 2015;2:e76-e77.

  28. Moir S Connors M Fauci A. The Immunology of HIV Infection in Bennett JE Dolin R Blaser MJ Mandell’s Principles and Practice of Infectious Diseases. Elsevier Philadelphia 8th Edition 2015;1526-1541.

  29. Overbaugh J Morris L. The Antibody Response against HIV-1. Cold Spring Harb Perspect Med 2012;2: a007039.

  30. Dinkins C Pilli M Kehrl K. Roles of autophagy in HIV infection. Immunol Cell Biol 2015; 93:11-17.

  31. Killian MS. Dual role of autophagy in HIV-1 replication and pathogenesis. AIDS Res Ther 2012;9:16-29

  32. Sterling TR Chaisson RE. General Clinical Manifestations of HIV Infection (Including the Acute Retroviral Syndrome and Oral, Cutaneous, Renal, Ocular, Metabolic, and Cardiac Diseases) in Bennett JE Dolin R Blaser MJ Mandell’s Principles and Practice of Infectious Diseases. Elsevier Philadelphia 8th Edition 2015; 1541-1557.

  33. Levy JA. HIV and the Pathogenesis of AIDS. ASM Press Washington 3th edition 2007.

  34. Domínguez-Molina MB León A Rodríguez C et al Analysis of Non-AIDSDefining Events in HIV Controllers. Clin Infect Dis 2016;62:1304-1309.

  35. Leon A Perez I Ruiz-Mateos E et al. Rate and predictors of progression in elite and viremic HIV-1 controllers. AIDS 2016; 30:1209-1220.

  36. Pereyra F Lo J Triant V et al. Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers. AIDS 2012;26:2409-2415.

  37. Kouri V Khouri R Alemán Y et al. CRF19_cpx is an Evolutionary fit HIV- 1 Variant Strongly Associated With Rapid Progression to AIDS in Cuba EBioMedicine. 2015; 2: 244–254

  38. Walker NF Scriven J Meintjes G. Immune reconstitution inflammatory syndrome in HIV-infected patients. HIV/AIDS – Research and Palliative Care 2015;7:49–64.

  39. Zheng Y Zhou H Yan Y et al. The Immune Pathogenesis of Immune Reconstitution Inflammatory Syndrome Associated with Highly Active Antiretroviral Therapy in AIDS. AIDS Res Hum Retr 2014; 30:1197-1209.




2020     |     www.medigraphic.com